PolyPeptide Group AG (SWX:PPGN)
Switzerland · Delayed Price · Currency is CHF 43.90
+0.10 (0.23%)
Aug 3, 2026, 2:45 PM CET
PolyPeptide Group AG Employees
PolyPeptide Group AG had 1,440 employees as of December 31, 2025. The number of employees increased by 78 or 5.73% compared to the previous year.
Employees
1,440
Change
78
Growth
5.73%
Revenue / Employee
251.72K CHF
Profits / Employee
-13.69K CHF
Market Cap
1.45B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 1,440 | 78 | 5.73% |
| Dec 31, 2024 | 1,362 | 89 | 6.99% |
| Dec 31, 2023 | 1,273 | 54 | 4.43% |
| Dec 31, 2022 | 1,219 | 118 | 10.72% |
| Dec 31, 2021 | 1,101 | 191 | 20.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Roche Holding AG | 103,249 |
| Novartis AG | 75,267 |
| Lonza Group AG | 20,141 |
| Galderma Group AG | 7,676 |
| Aevis Victoria | 4,870 |
| Tecan Group AG | 3,305 |
| SKAN Group AG | 1,737 |
| Medartis Holding AG | 1,337 |
PolyPeptide Group AG News
- 13 days ago - Samsung Biologics (005940) Proposes $1.8 Billion Acquisition of Polypeptide Group - GuruFocus
- 14 days ago - PolyPeptide Receives CHF 1.46 Bln Samsung Offer, Posts Strong H1 Prelim. Result, Raises Guidance - Nasdaq
- 14 days ago - Samsung Biologics to Acquire PolyPeptide Group for $1.8 Billion - GuruFocus
- 14 days ago - Samsung Biologics To Enter Peptide CDMO Market With CHF 1.46 Bln PolyPeptide Acquisition; Stock Down - Nasdaq
- 14 days ago - Samsung Biologics to acquire Switzerland's PolyPeptide Group in $1.8 billion all-cash deal - CNBC
- 27 days ago - PolyPeptide downgraded to Sector Perform from Outperform at RBC Capital - TheFly
- 6 weeks ago - PolyPeptide price target raised to CHF 38 from CHF 35 at Berenberg - TheFly
- 6 weeks ago - PolyPeptide price target raised to CHF 40 from CHF 33 at Barclays - TheFly